LIMINATUS PHARMA INC-CL A (LIMN) Stock Cash Flow
USA - NASDAQ:LIMN - US53271X1081 - Common Stock
1.73 USD
-0.23 (-11.73%)
1.73 USD
0 (0%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -2.90M | -1.23M | 10.25M | 4.37M | 0.00 | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | N/A | N/A | |||
| Change In Working Capital | -44.50K | 415.90K | 776.90K | 1.32M | 0.00 | |||
| Taxes Paid | 396.10K | 193.90K | N/A | N/A | N/A | |||
| Other non cash items | -157.60K | -1.28M | -12.12M | -6.90M | N/A | |||
| OPERATING CASH FLOW | -3.11M | -2.09M | -1.10M | -1.22M | 0.00 | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | 1.97M | 11.39M | 263.96M | -276.00M | N/A | |||
| INVESTING CASH FLOW | 1.97M | 11.39M | 263.96M | -276.00M | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 2.85M | 1.23M | 1.04M | N/A | N/A | |||
| Stock Issued/Repurchased | -1.80M | -10.66M | -263.96M | 283.07M | N/A | |||
| Other Financing Activity | N/A | N/A | 0.00 | -5.52M | N/A | |||
| FINANCING CASH FLOW | 1.05M | -9.43M | -262.92M | 277.55M | N/A | |||
| CHANGE IN CASH | -91.10K | -124.20K | -55.60K | 330.00K | 0.00 | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -3.11M | -2.09M | -1.10M | -1.22M | 0.00 | |||
| FREE CASH FLOW | -3.11M | -2.09M | -1.10M | -1.22M | 0.00 | |||
All data in USD